Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session IX: Immune Checkpoint Inhibitors for NSCLC
Debate: How to Handle PD-L1 > 50% - Use pembrolizumab + Histology Specific Chemo
Friday, November 11, 2022
1:05 PM – 1:12 PM
Debate Speaker(s)
Aaron Lisberg, MD
University of California, Los Angeles